(Q44818608)

6 December 2017

title

Evaluating the performance of the Framingham risk equations in a population with diabetes (English)

1 reference

6 December 2017

McEwan P

1

1 reference

6 December 2017

Williams JE

2

1 reference

6 December 2017

Griffiths JD

3

1 reference

6 December 2017

Bagust A

4

1 reference

6 December 2017

Peters JR

5

1 reference

6 December 2017

Hopkinson P

6

1 reference

6 December 2017

Currie CJ

7

1 reference

6 December 2017

publication date

1 April 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

21

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

318-323

1 reference

Cardiovascular disease risk profiles.

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01139.X

Coronary heart disease risk assessment in diabetes mellitus--a comparison of PROCAM and Framingham risk assessment functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01139.X

Using the Framingham model to predict heart disease in the United Kingdom: retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01139.X

Treating dyslipidaemia in primary care. The gap between policy and reality is large in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01139.X

Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01139.X

Indications for cholesterol-lowering medication: comparison of risk-assessment methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01139.X

Hospital utilization as a function of social deprivation: diabetes vs non-diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01139.X

NHS acute sector expenditure for diabetes: the present, future, and excess in-patient cost of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01139.X

Estimating the prevalence of diagnosed diabetes in a health district of Wales: the importance of using primary and secondary care sources of ascertainment with adjustment for death and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01139.X

The prevalence of multiple diabetes-related complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01139.X

Patterns of in and out-patient activity for diabetes: a district survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01139.X

Patterns and costs of hospital care for coronary heart disease related and not related to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01139.X

Epidemiology and costs of acute hospital care for cerebrovascular disease in diabetic and nondiabetic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01139.X

Estimation of unascertained diabetes prevalence: different effects on calculation of complication rates and resource utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01139.X

Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01139.X

10.1111/J.1464-5491.2004.01139.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference